NEW YORK (GenomeWeb News) – Pacific Biosciences reported after the close of the market Tuesday that its third quarter 2013 revenues climbed 164 percent year over year and grew 23 percent sequentially.

The Menlo Park, Calif.-based single-molecule sequencing technologies firm reported Q3 revenues of $7.4 million, compared to just $2.8 million in Q3 2012 and up from $6 million in Q2 2013. It beat the consensus Wall Street estimate of $7.1 million in revenues for the quarter.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: new gene linked to ocular coloboma, new statistical model for interrogating gene expression networks, and more.

With a new collection, PLOS highlights negative results it has published.

A pair of researchers examines political leanings and views on genomics, finding more of a role for optimism and pessimism in people's views.

The genome of the carnivorous bladderwort is smaller than many other plant genomes, but it still holds on to important genes.